Fatme Ghandour

Dr. Fatme Ghandour


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in JCO Precision Oncology
Verified
Journal Article
Open access
JAJoao V. Alessi
Joao V. Alessi
JLJames R. Lindsay
James R. Lindsay
AGAnita Giobbie-Hurder
Anita Giobbie-Hurder
BSBijaya Sharma
Bijaya Sharma
KFKristen Felt
Kristen Felt
SRScott J. Rodig
Scott J. Rodig
PURPOSE: Retrospective studies have found associations between the number of intratumoral immune cells and patient outcomes for specific cancers treated with targeted therapies. However, the clinical value of routinely quantifying intratumoral immune biomarkers using a digital pathology platform in the pan-cancer setting within an active clinical laboratory has not been established. METHODS: We developed ImmunoProfile, a daily clinical workflow that integrates automated multiplex immunofluorescence tissue staining, digital slide imaging, and machine learning–assisted scoring to quantify intratumoral CD8 + , PD-1 + , CD8 + PD-1 + , and FOXP3 + immune cells and PD-L1 expression in formalin-fixed, paraffin-embedded tissue samples in a standardized and reproducible manner. We prospectively applied ImmunoProfile to biopsies collected from 2,023 unselected patients with cancer over a 3-year period in the clinical laboratory and correlated the results with patient survival. RESULTS: In the pan-cancer cohort, patients with high numbers of intratumoral CD8 + or PD-1 + cells in had significantly lower risks of death compared with those with low numbers (CD8 + : high v low hazard ratio [HR], 0.62 [95% CI, 0.48 to 0.81], Wald P = .002; PD-1 + : high v low HR, 0.65 [95% CI, 0.51 to 0.83]; P = .0009) after adjusting for risk factors, including cancer type. In subset analyses, patients with high numbers of intratumoral CD8 + , PD-1 + , and/or CD8 + PD-1 + cells showed lower risks of death from non–small cell lung, colorectal, breast, esophagogastric, head and neck, pancreatic, and ovarian cancers after considering clinical risk factors, including American Joint Committee on Cancer stage, and despite varying therapies (all P < .05). CONCLUSION: Routinely quantifying intratumoral CD8 + and PD-1 + cells with a clinically validated digital pathology platform predicts patient survival across major cancer types, independent of clinical stage and despite diverse treatment regimens.

29 May 2026 in Cancer Prevention Research
Verified
Journal Article
Open access
MGMaria Gonzalez-Pons
Maria Gonzalez-Pons
RDRicardo L. Dominguez
Ricardo L. Dominguez
EMEleazar E. Montalvan-Sanchez
Eleazar E. Montalvan-Sanchez
NFNathan R. Foster
Nathan R. Foster
CSCarrie A. Strand
Carrie A. Strand
MCMarcia Cruz-Correa
Marcia Cruz-Correa
Globally, gastric adenocarcinoma is the fourth leading cause of cancer mortality and a major cancer disparity in the United States. Chemoprevention strategies are lacking for high-risk individuals with gastric premalignant conditions (GPMC). Curcumin, the principal curcuminoid in turmeric, exerts immunomodulatory effects in the epithelium and against Helicobacter pylori, and studies suggest chemoprevention potential. We conducted a double-blind, phase IIa randomized controlled trial in high-risk populations in Puerto Rico and Honduras. We investigated the utility of a bioavailable formulation of curcumin (Meriva) among individuals with H. pylori–negative GPMC, specifically, multifocal atrophic gastritis (MAG) or gastric intestinal metaplasia (GIM). Patients were 1:1 randomized to 1,000 mg Meriva daily or placebo for a 6-month intervention with endoscopy at baseline and 6 months. Outcomes included assessment of epithelial cytokine and chemokine levels, histology, and DNA damage as assessed by γ-H2AX phosphorylation IHC. Of the 110 subjects screened, 50 participants were randomized, and 48 completed the trial. A significant reduction in gastric mucosal IL1β levels from baseline in the gastric body, the primary endpoint, was observed in the Meriva group (P = 0.032). Changes in epithelial IL8, TNFα, and inducible protein 10 levels and gastric mucosal histology and DNA damage (secondary endpoints) were similar between arms. Curcumin (Meriva) was safe, well-tolerated, and showed potential as a curcuminoid chemoprevention agent in H. pylori–negative patients with GPMC. A potential reduction in gastric inflammation as measured by gastric mucosal IL1β levels was observed. Further studies are warranted, including studies in H. pylori–positive individuals, based upon the curcuminoid direct effects on H. pylori. Prevention Relevance: Gastric adenocarcinoma is a leading cause of cancer mortality worldwide. Chemoprevention candidates for GPMCs are limited. This randomized phase IIa trial evaluated a bioavailable curcumin formulation in high-risk individuals with MAG and GIM. The results support further study of curcuminoids for gastric cancer risk reduction. See related article by Morgan et al., p. XX . See related article by Park and Moy, p. XX .

18 December 2024 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
FGFatme Ghandour
Fatme Ghandour
SASarah Anderson
Sarah Anderson
Sameer Al DiffalhaSameer Al Diffalha
Sameer Al Diffalha
Intrahepatic cholangiocarcinoma is a primary liver malignancy with poor prognosis and limited treatment options. Lymphoepithelioma-like intrahepatic cholangiocarcinoma is an exceedingly rare variant of intrahepatic cholangiocarcinoma that histologically resembles nasopharyngeal carcinoma, previously known as lymphoepithelioma. It was first reported by Hsu et al in 1996 and they were able to show the presence of Epstein-Barr virus in tumor cells. Even though several risk factors for the development of intrahepatic cholangiocarcinoma have been identified, the association between Epstein-Barr virus and intrahepatic cholangiocarcinoma is relatively rare. This article aims at discussing a female patient's lymphoepithelioma-like intrahepatic cholangiocarcinoma tumor and summarizing the existing literature on Epstein-Barr virus-positiveLymphoepithelioma-like intrahepatic cholangiocarcinoma, including the clinical features, pathogenesis, diagnostic challenges, treatment approaches, prognosis, and histopathologic description.

20 December 2024 in Pathology - Research and Practice
Verified
Journal Article
Closed access
FGFatme Ghandour
Fatme Ghandour
KGKesley D. Green
Kesley D. Green
EJEkta Jain
Ekta Jain
PBPrachi Bajpai
Prachi Bajpai
CPChirag R. Patel
Chirag R. Patel
Sameer Al DiffalhaSameer Al Diffalha
Sameer Al Diffalha

15 April 2025 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
EJEkta Jain
Ekta Jain
FAFalone Amoa
Falone Amoa
RMRaima Memon
Raima Memon
NKNiraja Korremla
Niraja Korremla
IAImran Ajmal
Imran Ajmal
Sameer Al DiffalhaSameer Al Diffalha
Sameer Al Diffalha
Ectopic liver is a rare congenital anomaly characterized by the presence of liver tissue outside the normal liver without any direct connection to it. These lesions are usually detected incidentally during clinical evaluation for other issues. However, they sometimes mimic neoplastic lesions both clinically and radiologically, which poses diagnostic challenges. Here, we present 5 patients with ectopic liver, 4 of which mimicked neoplastic lesions. The first was a 54-year-old woman diagnosed with multiple liver lesions and an enlarged gastro-hepatic lymph node, suspected to be a primary hepatic neoplasm with metastasis. Upon resection, it was found to be a hepatocellular adenoma in the liver and intraabdominal ectopic liver tissue with a small hepatocellular adenoma. Patient 2 was a 36-year-old woman presenting with palpitations and shortness of breath. An echocardiogram revealed a right atrial mass, which was identified as ectopic liver upon microscopic examination. The third patient was a 57-year-old woman with intermittent abdominal pain who underwent cholecystectomy. Microscopy revealed ectopic liver tissue on the gallbladder's serosal surface, along with chronic cholecystitis. The fourth was a 36-year-old woman with a gallbladder polyp, which on microscopy revealed ectopic liver tissue with no other abnormalities in the gallbladder. The fifth patient was a 57-year-old woman presenting with shortness of breath, weakness, and right atrial mass, which was confirmed as ectopic liver. These patients illustrate varied presentations of ectopic liver, sometimes mimicking neoplasia. Hepatocellular adenomas arising in ectopic liver and ectopic liver in intracardiac locations are extremely rare and can be a diagnostic pitfall, as they can clinically, radiologically, and pathologically mimic serious conditions like neoplasia.

15 April 2025 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
EJEkta Jain
Ekta Jain
EOEric Ollila
Eric Ollila
FGFatme Ghandour
Fatme Ghandour
AAAbrar Alghamdi
Abrar Alghamdi
SBSamuel Borak
Samuel Borak
Sameer Al DiffalhaSameer Al Diffalha
Sameer Al Diffalha
Langerhans cell histiocytosis is a rare disorder marked by monoclonal proliferation of Langerhans cells, primarily affecting the skin and bones. Isolated gastrointestinal tract involvement by Langerhans cell histiocytosis in adults is exceedingly rare, with only a few examples documented to date. Here, we report two patients with adult Langerhans cell histiocytosis with gastrointestinal tract involvement, accompanied by BRAF mutation analysis. Patient 1 was a 51-year-old man presenting with intermittent abdominal pain. Colonoscopy revealed five polyps, with histopathology and immunohistochemistry confirmation of Langerhans cell histiocytosis. BRAF testing was positive for the V600E mutation. Patient 2 was a 76-year-old woman, who presented with anemia and recurrent C. difficile colitis, leading to gastrointestinal distress and weight loss. Colonoscopy revealed two polyps which on pathologic evaluation were diagnosed as Langerhans cell histiocytosis. BRAF testing was negative. Both the patients exhibited benign clinical course with no multisystem involvement. Though Langerhans cell histiocytosis involvement of the gastrointestinal tract is uncommon in adults, it should be considered in differential diagnoses when histiocytic proliferation is observed.